Product
Immunochemotherapy
Aliases
Albumin-bound paclitaxel, Carboplatin, Cisplatin, immunochemotherapy (3 other aliases)
Name
immunochemotherapy
2 clinical trials
3 indications
Indication
Head and Neck Squamous CarcinomaIndication
NSCLCIndication
Anti-AngiogenesisClinical trial
Neoadjuvant Stereotactic Body Radiotherapy（SBRT）Combined With Immunotherapy for Locally Advanced Head and Neck Squamous Cell CarcinomaStatus: Recruiting, Estimated PCD: 2026-12-31
Clinical trial
A Phase II, Prospective, Randomized, Open Label, Multi-center Study of Tislelizumab Combined With Anlotinib and Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant With Resectable Stage II-IIIB Non-Small Cell Lung CancerStatus: Not yet recruiting, Estimated PCD: 2025-06-10